| Home | E-Submission | Sitemap | Editorial Office |  
top_img
     
ORIGINAL ARTICLE 2022 September 6
Radiotherapy, volume reduction, and short-term surgical outcomes in the treatment of large myxoid liposarcomas
Purpose: While tumor volume reduction following radiation has been documented in myxoid liposarcomas, it is unclear whether large tumors experience similar volume reduction to smaller tumors. Materials and Methods: MRI studies performed before and after completion of pre-opera...
ORIGINAL ARTICLE 2022 September 8
Dosimetric analysis of intracavitary brachytherapy applicators: a practical study
Purpose: Intracavitary brachytherapy is one of the important methods of gynecological cancer treatment. The effect of attenuation is not considered in the dose calculation method released by the American Association of Physicists in Medicine (AAPM) Task Group No. 43 Report (TG-4...
ORIGINAL ARTICLE 2022 September 27
Bone-only oligometastatic prostate cancer: can SABR improve outcomes? A single-center experience
Purpose: Ablative treatment of oligometastases has shown survival benefit with certain tumors, although these effects still are to be demonstrated in prostate cancer. Materials and Methods: We analysed the toxicity and clinical control results obtained in patients with bone-on...
ORIGINAL ARTICLE 2022 September 30
A comparison between high dose rate brachytherapy and stereotactic body radiotherapy boost after elective pelvic irradiation for high and very high-risk prostate cancer
Purpose: To compare biochemical recurrence-free survival (BRFS) and toxicity outcomes of high dose rate brachytherapy (HDRB) and stereotactic body radiotherapy (SBRT) boost after elective nodal irradiation for high/very high-risk prostate cancer. Materials and Methods: a retro...
CASE REPORT 2022 September 29
Mucoepidermoid carcinoma of the trachea in a 9-year-old male child: case report and review of literature
Mucoepidermoid carcinoma (MEC) is most common malignancy of minor salivary glands in adults. Pulmonary MEC is extremely uncommon comprising of only 0.1%–0.2% of the primary lung malignancies and

If anyone registers his/her email address, he or she will receive the email of notification when new paper is published in the web site of Radiation Oncology Journal. Since it is open access journal, the full text is freely available.
Please Sign up.
Current Issue
Volume 40(3); September 2022
RSS feed

Articles in E-pub version are posted online ahead of regular publication.

E-Submission
Principles of Transparency and Best Practice
Author's Index
KOSRO
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
HDX Corporation
Elekta Korea
Editorial Office
Department of Radiation Oncology, Seoul National University Hospital,
Hamchun Hall, 6F, 95 Daehak-ro, Jongno-gu, Seoul 03082, Republic of Korea
Tel : +82-2-743-6574
E-mail: roj@kosro.or.kr
Copyright © The Korean Society for Radiation Oncology.                      Developed in M2PI
Close layer
prev next